2 Articles by Jeremy Weleff
The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.
Psychiatry research – March 15, 2025
Summary
With opioid overdose deaths at alarming rates, exploring new treatments is crucial. Recent findings suggest psychedelics like ibogaine and ketamine may offer promise for opioid use disorder. While studies show potential benefits, many lack rigorous design. Future research could refine these therapies, including psilocybin and LSD, for better outcomes.
Abstract
Opioid-related overdose deaths have reached record high levels, and novel treatments for opioid use disorder (OUD) are needed. The three United Sta...
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey.
Psychedelic medicine (New Rochelle, N.Y.) – March 01, 2024
Summary
A significant shift in attitudes is emerging among American psychiatrists regarding the use of hallucinogens. A recent survey revealed that 81% believe these psychedelics hold promise for treating psychiatric conditions, with many planning to incorporate psychedelic-assisted therapy into their practice, pending regulatory approval.
Abstract
Psilocybin, a classic hallucinogen, may eventually be approved by the United States Food and Drug Administration for treatment-resistant depression...